139 related articles for article (PubMed ID: 6889876)
1. Effect of the immunomodulant 2-cyanaziridine derivative BM 41.332 on adjuvant arthritis in the rat.
Bicker U
Arzneimittelforschung; 1982; 32(7):746-52. PubMed ID: 6889876
[TBL] [Abstract][Full Text] [Related]
2. [Biological effects of leakadin].
Garin AM; Lichinitser MR; Dmitrieva NV; Rubtsov BI; Leneva NV
Vopr Onkol; 1988; 34(2):192-6. PubMed ID: 2964757
[TBL] [Abstract][Full Text] [Related]
3. [Immunomodulating effect of the novel water-soluble gossypol derivative Mebavin in adjuvant arthritis].
Sabirova FM; Urazmetova MD; Madaminov AA
Eksp Klin Farmakol; 2004; 67(2):51-4. PubMed ID: 15188763
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl]propionic acid. 4th communication: inhibitory effects on rat adjuvant arthritis.
Tsurumi K; Kokuba S; Okada K; Yanagihara M; Fujimura H
Arzneimittelforschung; 1986 Dec; 36(12):1810-7. PubMed ID: 3566842
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of BM 12,531 (Prop. INN azimexon).
Bicker U
Recent Results Cancer Res; 1980; 75():147-52. PubMed ID: 7232826
[TBL] [Abstract][Full Text] [Related]
6. Rat adjuvant arthritis as a model to test potential antirheumatic agents.
Toivonen ML; Tokola O; Vapaatalo H
Methods Find Exp Clin Pharmacol; 1982; 4(6):359-63. PubMed ID: 7144330
[TBL] [Abstract][Full Text] [Related]
7. Influence of ciamexon on blood glucose and insulin requirement in newly manifested type I diabetics. Results of a pilot study.
Hogan M; Beyer J; Stuermer W; Weber P; Schrezenmeier J
Arzneimittelforschung; 1988 Aug; 38(8):1185-9. PubMed ID: 3058137
[TBL] [Abstract][Full Text] [Related]
8. [Influence of prodigiozan, methyluracil and levamisole on the anti-inflammatory effect of nonsteroid antiphlogistics].
Bogdanova ASh
Antibiotiki; 1984 Jun; 29(6):453-6. PubMed ID: 6476809
[TBL] [Abstract][Full Text] [Related]
9. Carcinostatic action of 2-cyanaziridines against a sarcoma in rats.
Bicker U; Fuhse P
Exp Pathol (Jena); 1975; 10(5-6):279-84. PubMed ID: 1233288
[TBL] [Abstract][Full Text] [Related]
10. [A new feasibility of immune stimulation in diseases with reduced cell immunity? (author's transl)].
Pavelka K; Müller W
Cas Lek Cesk; 1981 May; 120(19):566-70. PubMed ID: 7237501
[No Abstract] [Full Text] [Related]
11. The effect of BM 12.531 (azimexon) on natural killer cell activity in myeloma patients.
Peter HH; Dziuba-Traber H; Boerner D
Eur J Cancer Clin Oncol; 1984 Mar; 20(3):353-9. PubMed ID: 6368246
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and immunomodulating properties of grape melanin. Inhibitory effects on paw edema and adjuvant induced disease.
Avramidis N; Kourounakis A; Hadjipetrou L; Senchuk V
Arzneimittelforschung; 1998 Jul; 48(7):764-71. PubMed ID: 9706378
[TBL] [Abstract][Full Text] [Related]
13. Changes in the adhesive phenotype of regional lymphocytes in rats with adjuvant arthritis: alteration by cyclophosphamide.
Altankov G; Marinova-Mutafchieva L; Nikolaeva N; Penkova R
Methods Find Exp Clin Pharmacol; 1991 May; 13(4):263-8. PubMed ID: 1875775
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of whole bee venom in adjuvant-induced arthritis.
Lee JY; Kang SS; Kim JH; Bae CS; Choi SH
In Vivo; 2005; 19(4):801-5. PubMed ID: 15999553
[TBL] [Abstract][Full Text] [Related]
15. [Development and clinical use of chemical immunomodulators].
Abe T
Nihon Rinsho; 1981 Apr; 39(4):1893-901. PubMed ID: 6796722
[No Abstract] [Full Text] [Related]
16. On the possible anti-rheumatic effects (immuno-effector?)of imidazole derivatives (levamisole, clotrimazole, niridazole).
Delbarre F
Biomedicine; 1977 Apr; 27(3):97-8. PubMed ID: 556383
[TBL] [Abstract][Full Text] [Related]
17. [Immunomodulating therapy of adjuvant disease in rats].
Sibiriak SV; Lazareva DN; Khaĭbullina SF
Farmakol Toksikol; 1988; 51(2):72-4. PubMed ID: 3378610
[TBL] [Abstract][Full Text] [Related]
18. Three new agents for immunotherapy trials: azimexon, bestatin, and tuftsin.
Mathé G; Florentin I; Bruley-Rosset M; Goutner A; Serrou B
Recent Results Cancer Res; 1982; 80():331-3. PubMed ID: 6977171
[No Abstract] [Full Text] [Related]
19. A new model of experimental arthritis induced by an aqueous form of synthetic adjuvant in immunodeficient rate (SHR and nude rats).
Kohashi O; Kohashi Y; Kotani S; Osawa A
Ryumachi; 1981; 21 Suppl():149-56. PubMed ID: 7344125
[No Abstract] [Full Text] [Related]
20. Influence of various forms of dialyzable leukocyte extracts on rat adjuvant arthritis.
Stanciková M; Rovenský J; Pekárek J; Orviský E; Blazícková S; Cech K
Arch Immunol Ther Exp (Warsz); 1994; 42(4):295-9. PubMed ID: 7487370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
